News
Commemorating Indigenous Peoples’ Day: What American Indian/Alaska Native People Should Know About Melanoma
30 October 2024 In Allies & Partnerships, Prevention, Science
Indigenous Peoples' Day, which commemorates American Indian/Alaska Native history, traditions, and culture, was celebrated across the US on October 14, 2024. In honor of these celebrations, we highlight what American Indian/Alaska Native people should know about melanoma.
Prioritizing Sun Protection for the Outdoor Enthusiast Community: Bimini Bay Outfitters
By Renee Orcione, MRA Digital Engagement & Communications Manager | 28 October 2024 In Allies & Partnerships, Prevention
“As a company who both employs and serves the outdoor enthusiast community, sadly most of us know somebody who has been affected by skin cancer,” Bimini Bay Outfitters (BBO) President Bob Feldsott shared.
Engaging Kids and Families in Sun Safety: The Sunscreaming Summer Graphic Novel
By Renee Orcione, MRA Digital Engagement & Communications Manager | 25 October 2024 In Allies & Partnerships, Prevention
In New York City, Dr. Tamara Lazic Strugar has made her mark as a leading dermatologist and a champion of skin health education. Trained at Yale University, Dr. Lazic Strugar has devoted her career to both treating and educating patients and empowering the next generation of dermatologists.
Clinical Trials to Watch: September 2024
By Joan Levy, PhD - MRA Chief Science Officer | 26 September 2024 In Allies & Partnerships, News, Science, Treatment
Treatment of advanced melanoma has dramatically improved over the past decade with 17 new therapies approved by the Food and Drug Administration (FDA). Even with these treatment advances, 50% of patients with advanced melanoma will either not respond to any of these treatments or their disease will progress, creating a...
IGNYTE-3 Trial: Harnessing the Power of Viruses to Activate the Immune System and Treat Advanced Melanoma
23 September 2024 In Allies & Partnerships, Events, News, Science, Treatment
Although treatment options for advanced melanoma have improved, many patients still will not benefit from currently approved therapies. In particular, some patients treated with anti-PD1 immunotherapy never respond (called primary resistance) and others initially respond and then their disease progresses (called secondary resistance).
WATSKIN Founder Lois Robbins' Journey from Diagnosis to Stylish Sun Protection
By Stephanie Kauffman, MRA President & COO | 12 September 2024 In Allies & Partnerships, Events, Melanoma Stories, Prevention
Though the summer is officially over according to the calendar, the sun's harmful ultraviolet (UV) rays never take a break. Fall serves as an important time to remember and emphasize the importance of protecting our skin year round.
2025 Scientific Retreat & Patient Forum Scholarship
9 September 2024 In Allies & Partnerships, Events, Melanoma Stories, Prevention, Science, Treatment
MRA’s Patient Advocate Scientific Retreat & Patient Forum Scholarship encourages the engagement, education, and inclusion of patient advocates in melanoma research by providing support for their attendance at the Annual Melanoma Exchange Patient Forum and Scientific Retreat.
Investigating CAR-T Cell Therapy for Advanced Melanoma
By Renee Orcione, MRA Digital Engagement & Communications Manager | 28 August 2024 In Allies & Partnerships, News, Science, Treatment
One of the greatest scientific breakthroughs in melanoma research has been the FDA approval of cancer immunotherapy treatments called checkpoint inhibitors. These treatments stimulate the body’s own immune system to fight off melanoma. Checkpoint immunotherapies, first approved in melanoma, are now being used to treat a number of different cancer types.
Sun Safety Spotlight: Dawn Stringer’s Early-Stage Melanoma Diagnosis
By Renee Orcione, MRA Digital Engagement & Communications Manager | 30 July 2024 In Allies & Partnerships, Melanoma Stories, Prevention, Treatment
Being a child of the 90s, sun safety wasn’t a top priority for Dawn Stringer. “I remember always having pink shoulders,” said Dawn of growing up in sunny Myrtle Beach, South Carolina. Whether from the sun or from tanning beds, having a tan seemed essential.
RARE Registry: Providing Hope Through Innovation
26 July 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment
Each year approximately 5,000 patients are diagnosed with acral or mucosal melanoma. These rare melanoma subtypes arise in non-sun exposed areas and are not believed to be caused by UV damage. Due to the relative obscurity of these rare subtypes, patients face mounting challenges ranging from late diagnoses, lack of support,...